ArisGlobal to Discuss AI Enabled Data Fabric and Emerging Pharmacovigilance Technologies at World Drug Safety
The life sciences R&D technology leader will lead keynote sessions ...
ArisGlobal LifeSphere MultiVigilance is Selected By Asahi Kasei Pharma
Miami, Florida, Tokyo, August 23, 2021 Asahi Kasei Pharma Corp. ...
ArisGlobal’s LifeSphere IDMP Requirements, Readiness and Capabilities Acknowledged in Gens & Associates Report
ArisGlobal LifeSphere IDMP Requirements, Readiness and Capabilities Acknowledged in Gens ...
ArisGlobal Awarded Frost & Sullivan 2021 North America Customer Value Leadership
ArisGlobal recognized by Frost & Sullivan for enabling life sciences ...
ArisGlobal Highlights R&D Innovation, Digital Transformation, and AI at Breakthrough2021
Life sciences leader announces virtual conference to spotlight trends that ...
Xihua Scientific Selects LifeSphere MultiVigilance to Advance Pharmacovigilance Services
Fast-growing CRO uses the only automated, end-to-end safety system to ...
Nordic Capital Invests Further in Fast-Growing ArisGlobal, a Leading Provider of Cloud Software for the Life Sciences Industry
As a leading healthcare and technology investor and committed owner, ...
New Regulatory Capabilities Position ArisGlobal for Future Growth, Report Says
ArisGlobal Recognized in Gens & Associates “RIM Software Provider Landscape” ...
Dr. Reddy’s Laboratories Selects LifeSphere® Signal and Risk Management
The leading multination pharmaceutical company plans to use ArisGlobal’s platform ...
Zelgen Selects Industry’s First Automated, End-to-End Drug Safety System
Rapidly growing biopharma selects ArisGlobal's LifeSphere® MultiVigilance 10, benefits from ...
